Ten‐day triple therapy <i>versus</i> sequential therapy <i>versus</i> concomitant therapy as first‐line treatment for <i><scp>H</scp>elicobacter pylori</i> infection

Abstract

TT, ST, and CT all achieved eradication rates above 80% on ITT and above 90% on MITT and PP analyses. Dual resistance and lack of compliance were predictors of treatment failure (clinicaltrials.gov: NCT02092506).